General Research Grant | Mechanism or Pathway of Disease
Funded Grants
FARA-Funded Research Grants
General Research Grant | Drug Discovery
Pre-clinical assessment of protein replacement therapy in the central nervous system of Friedreich’s ataxia mouse models
Kyle Bryant Translational Research Award | Lead Candidates
Advancing FA Treatment: Exploring the Pharmacology of Neonatal Cardiac Progenitor Cells for Cardiac and Neuroprotection
Award for Innovative Mindset (AIM) | Mechanism or Pathway of Disease
Exploring the Role of Extracellular Traps in the Pathogenesis of Friedreich’s Ataxia
Graduate Research Fellowship | Mechanism or Pathway of Disease
Does Frataxin Deficiency Disrupt GluR2 Trafficking in the Cerebellum via Defects in Palmitoylation?
General Research Grant | Outcome Measures & Biomarkers
Leveraging Real-World Data to Define Clinical Milestones and Assess Pharmacologic Impact in Friedreich’s Ataxia Progression
Graduate Research Fellowship | Mechanism or Pathway of Disease
Preclinical evaluation of novel targets for FRDA cardiomyopathy
General Research Grant | Mechanism or Pathway of Disease
Lipidomic profiling and analyses of Friedreich’s Ataxia iPSC-derived dorsal root ganglia sensory neurons
Award for Innovative Mindset (AIM) | Mechanism or Pathway of Disease
Histone H3 Enzyme Activity as a Regulator of Iron-Sulfur Cluster Stability in Friedreich’s Ataxia
Award for Innovative Mindset (AIM) | Mechanism or Pathway of Disease
Investigating new epigenetic repressor complexes involved in silencing the FXN locus in cells from FRDA patients
Award for Innovative Mindset (AIM) | Mechanism or Pathway of Disease
The N-terminus of frataxin and its role in FRDA
Award for Innovative Mindset (AIM) | Cell & Animal Models